Latest updates on the WHO 3rd Global Patient Safety Challenge
“Medication without Harm”
Moderator: Rabih Dabliz
Type of Session: Knowledge – Based
Session Program:
| Time | Speaker | Topic |
| 09:00-09:15 | Qamra Al-Sarari
Director General of Quality Assurance Center |
Key note and Introduction |
| 09:15-09:35 | Mondher Letaief, MD, MPH
Regional Adviser, Quality and Safety Department of Universal Health Coverage Health Systems World Health Organization – EMRO |
Updates on the WHO Patient Safety Global Challenge: “Medication without Harm” |
| 09:35-09:50 | Lina R. Bader PhD RPharmS Lead for Workforce Transformation & Development at International Pharmaceutical Federation (FIP) | Patient & Medication Safety: Pharmacists’ Perspective and Contribution |
| 09:50-10:10 | Sara Albalushi Sr. Specialist Pharmacist
Director pharmaceutical Care. MOH.Oman |
Ministry of Health Response to Medication without Harm Challenge
“Pharmaceutical Care Initiatives” |
| 10:10-10:40 | Coffee Break | |
| 10:40-11:00 | Thamir M. Alshammari, RPh, Ph.D, M.S, FISoPAdvisor, Saudi Food and Drug uthority Executive President Associate Professor of Pharmacy Practice Senior researcher, Medication Safety Research Chair, King Saud University President, International Society of Pharmacovigilance Middle East
Pharmacoepidemiology and Pharmacovigilance Consultant ,Riyadh KSA |
Medication without harm: Saudi Arabia Experiences |
| 11:00-11:20 | Mohammed Alshennawi, B.Sc. Pharm., M.B.A. General Director, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia. | Shifting Toward Safety Culture – The Saudi Ministry of Health Experience |
| 11:20-11:40 | Alpana Mair FFRPS,IP, MRPharmS
Head of Effective Prescribing and Therapeutics, Scottish Government Scottish Quality, Safety & Improvement Fellow.UK |
Addressing Medication Safety in Polypharmacy and High Risk Medications |
| 11:40-12:00 | Charlotte Rossing, M Sc (Pharm), PhD.
Director of R&D, Pharmakon, Danish College of Pharmacy Practice. Denmark |
Danish Initiatives to Support WHO Initiative “Medication Without Harm” and How to Measure if Success |
| 12:00-12:20 | Carolyn Hoffman RN MN President and CEO Institute for Safe Medication Practices Canada (ISMP Canada) System. Canada |
Responding to the WHO Global Challenge: Reporting, Learning and Engaging to Improve Medication Safety in Canada” |
| 12:20-12:40 | John Hertig, PharmD, MS, CPPS, FASHP
Associate Professor and Vice-Chair of Pharmacy Practice Butler University College of Pharmacy and Health Sciences |
High-Risk but no Harm: USA Strategies for Using Human Factors Science to Improve Patient Safety. |
| 12:40-13:00 | MARK LOCK , BSc, BPharm, MBA, AGIA, AACPA Business Development Manager for Terry White Chemmart Pharmacies
Australia |
Advances in Medicines Safety :
The role of pharmacists |
| 13:00-13:20 | Ciara Kirke
Clinical Lead, National Medication Safety Program, Health Service Executive, Ireland |
Partnering with People Using Medicines – the key to Ireland’s Response to the Medication Without Harm Challenge |
| 13:20-13:50 | Discussion | |
| 13:50-14:50 | Lunch | |